Bionano Genomics, Inc.
BNGO
$1.13
-$0.03-2.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 19.27M | 21.58M | 16.44M | 18.23M | 9.48M |
| Total Receivables | 5.21M | 4.53M | 3.49M | 3.35M | 4.77M |
| Inventory | 5.45M | 7.05M | 8.63M | 9.56M | 11.12M |
| Prepaid Expenses | 618.00K | 5.38M | 3.10M | 2.78M | 703.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 14.84M | 10.27M | 11.00M | 11.00M | 13.42M |
| Total Current Assets | 45.39M | 48.80M | 42.66M | 44.93M | 39.49M |
|
|
|||||
| Total Current Assets | 45.39M | 48.80M | 42.66M | 44.93M | 39.49M |
| Net Property, Plant & Equipment | 21.16M | 22.82M | 24.23M | 22.70M | 24.32M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.35M | 5.69M | 7.03M | 8.37M | 9.71M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.69M | 1.76M | 2.09M | 2.42M | 3.15M |
| Total Assets | 73.58M | 79.06M | 76.01M | 78.41M | 76.67M |
|
|
|||||
| Total Accounts Payable | 5.59M | 5.99M | 6.24M | 6.56M | 6.96M |
| Total Accrued Expenses | 4.63M | 3.70M | 2.29M | 2.71M | 4.62M |
| Short-term Debt | 9.98M | 9.83M | 11.76M | 13.04M | 20.36M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 946.00K | 1.28M | 1.60M | 1.85M | 3.25M |
| Total Finance Division Other Current Liabilities | 1.80M | 2.19M | 2.28M | 2.25M | 2.15M |
| Total Other Current Liabilities | 1.80M | 2.19M | 2.28M | 2.25M | 2.15M |
| Total Current Liabilities | 22.94M | 22.98M | 24.18M | 26.41M | 37.34M |
|
|
|||||
| Total Current Liabilities | 22.94M | 22.98M | 24.18M | 26.41M | 37.34M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 9.98M | 9.83M | 11.76M | 13.04M | 20.36M |
| Capital Leases | 5.97M | 6.09M | 6.22M | 3.53M | 3.68M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 249.00K | 192.00K | 243.00K | 292.00K | 267.00K |
| Total Liabilities | 29.16M | 29.26M | 30.64M | 30.23M | 41.30M |
|
|
|||||
| Common Stock & APIC | 764.03M | 761.48M | 748.57M | 744.50M | 728.57M |
| Retained Earnings | -719.62M | -711.69M | -703.18M | -696.33M | -693.23M |
| Treasury Stock & Other | 17.00K | 6.00K | -10.00K | 14.00K | 27.00K |
| Total Common Equity | 44.42M | 49.80M | 45.37M | 48.19M | 35.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 44.42M | 49.80M | 45.37M | 48.19M | 35.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 44.42M | 49.80M | 45.37M | 48.19M | 35.38M |
|
|
|||||